% Expired Patents = 16.7

EPO Patents = 7

Trademarks = 1

Forward Citations = 10

Loading Chart...

13 inventors (with patents filed for the assignee):

Marc Eloit (5 out of 9 patents)

Justine Cheval (3 out of 3 patents)

Charles Hebert (2 out of 2 patents)

4. Marc Lecuit (2 out of 2 patents)

5. Éric Cabannes (1 out of 1 patent)

6. Nicolas Torno (1 out of 2 patents)

7. Jean Deregnaucourt (1 out of 6 patents)

8. Marion Mouton (1 out of 2 patents)

9. Isabelle Heard (1 out of 2 patents)

10. Virginie Sauvage (1 out of 1 patent)

11. Philippe Perot (1 out of 8 patents)

12. Pascale Beurdeley (1 out of 1 patent)

13. Stéphane Cruveiller (1 out of 1 patent)

14. Erika Muth (0 patent)

6 patents: Sort by Forward Citations

1. 12077829 - Anellovirus genome quantification as a biomarker of immune suppression (2024-09-03),

2. 11542563 - Method for discriminating between live and dead microbes in a sample (2023-01-03),

3. 11530452 - Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus-associated cancer stages (2022-12-20),

4. 11293049 - Modulation of accessibility of host nucleic acids to nucleic acid digesting enzymes in acellular biological fluids (2022-04-05),

5. 10144975 - Anellovirus genome quantification as a biomarker of immune suppression (2018-12-04),

6. 9403880 - Identification of a human gyrovirus and applications (2016-08-02),

Pathoquest is a biotechnology company that specializes in the development of innovative solutions for infectious disease testing. Their proprietary technology allows for rapid and accurate identification of pathogens, leading to more effective treatments and improved patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

6 Patents

#501 in Paris

#2,485 in France

Paris, France

Pathoquest